A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics.
Ontology highlight
ABSTRACT: Gene vectors regulated by tumor-specific promoters to express transgenes specifically in cancer cells are an emerging approach for cancer diagnosis and treatment. Minicircles are shortened plasmids stripped of prokaryotic sequences that have potency and safety characteristics beneficial for clinical translation. Previously, we developed minicircles driven by the tumor-specific survivin promoter, which exhibits elevated transcriptional activity in aggressive cancers, to express a secreted reporter for blood-based cancer detection. Here we present the first activatable, cancer theranostic minicircle system featuring a pair of diagnostic and therapeutic minicircles expressing Gaussia luciferase for urine-based cancer detection or cytosine deaminase:uracil phosphoribosyltransferase for
SUBMITTER: Wang T
PROVIDER: S-EPMC7889447 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA